Sivelestat sodium alleviates sepsis-associated acute lung injury by inhibiting ferroptosis via the Nrf2/SLC7A11/GPX4 axis
Ying Wang, Xiaoling Xia, Yan Lu, ChengLiang Zhang, Yaqing Zhou, Jingjing Fan · 2026
Read Sivelestat sodium alleviates sepsis-associated acute lung injury by inhibiting ferroptosis via the Nrf2/SLC7A11/GPX4 axis by Ying Wang, Xiaoling Xia, Yan Lu, ChengLiang Zhang, Yaqing Zhou, Jingjing Fan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353525.txt.
Description
Wang and colleagues tested a drug for sepsis-linked lung injury in rats in a 2026 study. Sepsis, a runaway response to infection, often floods and scars the lungs. Rats given the drug at three dose levels were compared with untreated sick rats and healthy controls.
Treated rats survived at higher rates, and the benefit grew with dose. Lung swelling, injury scores, and inflammatory signals fell at medium and high doses. A cell-death pathway driven by iron also weakened, tied to a protective gene chain the drug switched on. Low doses helped only a few measures. The dose pattern supports further study of the drug for this lung complication.
Catalog record
| CREATOR | Ying Wang, Xiaoling Xia, Yan Lu, ChengLiang Zhang, Yaqing Zhou, Jingjing Fan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55507 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |